Loading clinical trials...
Loading clinical trials...
A Double Blind, Placebo Controlled, Phase II, Randomized Study of Lovastatin Therapy in the Treatment of Mildly Active Rheumatoid Arthritis
Conditions
Interventions
Lovastatin
Placebo
Locations
15
United States
University of Alabama
Birmingham, Alabama, United States
University of California, San Francisco
San Francisco, California, United States
University of Colorado
Aurora, Colorado, United States
University of Chicago Medical Center
Chicago, Illinois, United States
Justus J. Fiechtner, MD, PLLC
Lansing, Michigan, United States
Feinstein Institute for Medical Research NS-LIJ Health System
Manhasset, New York, United States
Start Date
November 6, 2007
Primary Completion Date
April 30, 2012
Completion Date
April 30, 2012
Last Updated
September 7, 2022
NCT06329401
NCT06647069
NCT07484243
NCT06841562
NCT07268326
NCT07029555
Lead Sponsor
National Institute of Allergy and Infectious Diseases (NIAID)
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions